# R&D Cardiologie

Organization · id `cardio:org-r-d-cardiologie` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=R%26D+Cardiologie>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: R&D Cardiologie
- Sponsor class: OTHER

## Connected pages

- Sponsors: Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions (`cardio:ct-nct01516723`)
- Sponsors: Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy (`cardio:ct-nct04676880`)
- Sponsors: Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation (`cardio:ct-nct07021313`)

## Provenance

Content hash: aeb0531b34086ddbdee8e7e37ed9d6341ee75f756795372d818b48bf39d68a20
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
